Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Francesca Pezzetta"'
Publikováno v:
QJM. 102:817-820
Sir, In his informative commentary on the importance of primary prevention in reducing the burden of vascular disease,1 Dr Miller states that compliance problems with lifestyle changes facilitate the pharmacologic treatment with statins to achieve lo
Publikováno v:
Archives of medical research. 41(8)
Ezetimibe is a lipid-lowering agent that inhibits intestinal absorption of dietary cholesterol. It substantially lowers low-density lipoprotein cholesterol levels when used alone or in combination with statins. Although there is a growing push for th
We hypothesize that some of the mechanisms involved in the "epidemic" of nonmelanoma skin cancer might also be due to widespread use of cholesterol lowering statin drugs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de91a9ce1c098255f77a9689b27d23b6
https://europepmc.org/articles/PMC3084964/
https://europepmc.org/articles/PMC3084964/
Publikováno v:
Stroke. 39(11)
To the Editor: Goldstein et al1 reported a post hoc analysis of data from the Stroke Prevention with Aggressive Reductions in Cholesterol Levels (SPARCL) trial in order to determine the effects of high-dose atorvastatin in the secondary prevention of
Publikováno v:
Current Oncology
Volume 15
Issue 2
Pages 235-77
Volume 15
Issue 2
Pages 235-77
The Editor, Current Oncology December 24, 2007 In their commentary, Drs. Takahashi and Nishibori1 discuss putative antitumour effects of statins. However, prospective data suggest that statins actually increase cancer in certain segments of the popul
Publikováno v:
International journal of cardiology. 135(1)
Statin drugs are widely prescribed to achieve aggressive low-density lipoprotein lowering in order to decrease cardiovascular disease. Although some of the immunomodulatory effects of statins may stabilize atherosclerotic plaque, they may be harmful
Publikováno v:
Transplant Immunology. 23:224-225
We suggest that surveillance for squamous cell cancer might be particularly useful fortransplant patients receiving statin therapy. We recommend that development of non melanoma skincancer should be specified as a secondary endpoint in future large e
Publikováno v:
QJM. 102:435-436
Sir, Atherosclerosis is believed to be a chronic inflammatory disease affecting the intima of arteries.1 Controversy continues to surround its etiology and pathogenesis, particularly with respect to cholesterol and lipids.2 However, in his review,3 T
Autor:
Luca Mascitelli, Francesca Pezzetta
Publikováno v:
Neurology. 70:1720-1721
Blanco et al. studied a selected group of patients who were receiving statins before admission for acute hemispheric ischemic stroke and found that statin withdrawal for the first 3 days of hospitalization was associated with increased risk of death
Publikováno v:
The Primary Care Companion to The Journal of Clinical Psychiatry. 10:482
Sir: Evidence from randomized trials suggests that statins are very safe.1 Consequently, their widespread use is highly promoted, even in high doses, and among adults of all ages. However, we feel caution is warranted, particularly when striving for